Back to articles
Biology

The Role of AMH Testing in Fertility Planning

February 15, 20266 min read
The Role of AMH Testing in Fertility Planning

What Is AMH and Why Does It Matter?

Anti-Müllerian hormone (AMH) is a glycoprotein produced by the granulosa cells of small developing follicles in the ovary. Unlike most hormones involved in the menstrual cycle, AMH levels remain relatively stable throughout the cycle—making it an exceptionally convenient blood test that can be performed at any time, without the need for cycle-day-specific timing.

AMH's clinical value lies in what it reflects: the current size of the primordial follicle pool—your remaining egg supply. As ovarian reserve declines with age, AMH levels fall in parallel. A woman's AMH trajectory is largely determined by her biology and genetics, though lifestyle factors (particularly smoking) can accelerate decline. The result is that AMH provides a personalized snapshot of ovarian reserve that age alone cannot capture: two 35-year-old women can have dramatically different AMH levels and very different fertility outlooks.

Interpreting AMH Values

AMH is measured in nanograms per milliliter (ng/mL) or picomoles per liter (pmol/L), with some variation between laboratory assays. General reference ranges (using ng/mL):

  • Above 3.5 ng/mL: High — indicates a robust ovarian reserve, though extremely high values may suggest polycystic ovary syndrome (PCOS)
  • 1.5–3.5 ng/mL: Normal — suggests age-appropriate or above-average ovarian reserve
  • 1.0–1.5 ng/mL: Low-normal — still functional, but closer monitoring may be warranted
  • 0.5–1.0 ng/mL: Low — diminished ovarian reserve; fertility treatment planning should begin promptly
  • Below 0.5 ng/mL: Very low / diminished ovarian reserve — urgent consultation with a reproductive endocrinologist is recommended

These ranges are guidelines, not verdicts. A single AMH number should always be interpreted in the context of age, clinical history, antral follicle count (AFC), and other fertility markers.

"AMH is a powerful tool for fertility planning, but it is a measure of quantity—of how many eggs you may have remaining. It tells us less about egg quality, which is still primarily determined by age. The two must be considered together."

What AMH Can Tell You

AMH is most useful for:

  • Predicting response to ovarian stimulation: Women with higher AMH typically produce more eggs in response to gonadotropin stimulation, while those with low AMH may have diminished response. This informs IVF medication protocols and cycle planning.
  • Timing fertility treatment decisions: A low AMH in a woman who is not yet trying to conceive may prompt earlier consultation or fertility preservation, while a reassuringly normal AMH provides more confidence to delay.
  • Evaluating diminished ovarian reserve (DOR): Combined with AFC, AMH is the primary diagnostic tool for DOR.
  • Monitoring conditions that affect ovarian reserve: AMH testing is used before and after surgery (such as endometrioma removal or ovarian cystectomy) and chemotherapy to assess reserve preservation.

What AMH Cannot Tell You

AMH's limitations are as important as its strengths, and miscommunication about these limits causes significant unnecessary anxiety:

  • AMH does not measure egg quality. A woman with low AMH who is 28 years old will have much better egg quality than a woman with a similar AMH who is 38. Age remains the dominant determinant of chromosomal egg quality.
  • AMH does not predict natural conception probability for a given month. A low AMH may mean fewer eggs are released over a woman's remaining fertile years, but it does not mean zero—and natural pregnancies do occur with low AMH, including very low AMH.
  • AMH does not predict menopause timing with precision. While lower AMH generally suggests earlier depletion of the follicle pool, the relationship is probabilistic, not deterministic. Menopause timing is influenced by genetics and other factors that AMH does not fully capture.
  • AMH fluctuates. While more stable than FSH or estradiol, AMH can vary between cycles and laboratories. A single alarming result should be confirmed with a repeat test.

Who Should Get AMH Testing?

AMH testing is increasingly offered as a routine wellness check, but it is most clinically valuable for specific populations:

  • Women over 30 who are considering delaying pregnancy and want a clearer picture of their timeline
  • Women of any age who are actively trying to conceive and have not achieved pregnancy after 6–12 months
  • Women with a family history of premature ovarian insufficiency (early menopause)
  • Women who have had surgery involving the ovaries or treatment with chemotherapy or radiation
  • Women with endometriosis, which is associated with reduced ovarian reserve
  • Women considering egg freezing who want baseline data before deciding on timing

Interpreting Results with a Specialist

Direct-to-consumer AMH tests have made this biomarker more accessible, but accessibility without context creates its own problems. Women who receive a low AMH result via a consumer test often experience significant anxiety before speaking to a clinician—and that anxiety is frequently out of proportion to the actual clinical implications of their result.

If you undergo AMH testing—whether through your OB/GYN, a reproductive endocrinologist, or a consumer service—review the results with a clinician who can interpret them in the context of your full clinical picture, including your age, AFC, cycle regularity, and reproductive goals. AMH is most powerful as one piece of a comprehensive fertility assessment, not as a standalone number.

Actionable Next Steps

Regardless of your AMH result, the next steps follow a clear logic:

  • Normal AMH: Continue monitoring every 1–2 years if fertility planning is relevant; discuss timeline with your OB/GYN
  • Low-normal AMH: Consult with an REI; consider fertility preservation options; avoid unnecessary delay if pregnancy is desired
  • Low or very low AMH: Urgent REI consultation; evaluate all options including egg freezing (if eggs remain), donor egg consideration, and understanding of realistic expectations for natural and assisted conception

Knowledge is the foundation of good decision-making. AMH testing—interpreted correctly—gives you one of the clearest windows into your reproductive timeline available. Use it wisely.